We undertook a retrospective cohort study of women who had DIP (type 1, type 2 or gestational diabetes) birthing at National Women’s Health, Auckland, New Zealand, a tertiary obstetric referral hospital, between 1 January 2006 and 31 December 2016. ANC exposure was defined as any corticosteroid administration for the purpose of improving neonatal outcome from 22 completed weeks of pregnancy.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.